Development of a market projection methodology, based on clinical data, for decision making on investments in biosimilars

dc.creatorGottgtroy, Carla Lemos
dc.creatorMarques, Amanda de Miranda
dc.creatorDefendi, Hugo Garcia Tonioli
dc.creatorAraujo, Anna Erika Vieira de
dc.creatorMaia, Maria de Lourdes Sousa
dc.date2022-04-11T14:11:07Z
dc.date2022-04-11T14:11:07Z
dc.date2022
dc.date.accessioned2023-09-26T20:10:35Z
dc.date.available2023-09-26T20:10:35Z
dc.identifierGOTTGTROY, C. L. et al. Development of a market projection methodology, based on clinical data, for decision making on investments in biosimilars. In: INTERNATIONAL SYMPOSIUM ON IMMUNOBIOLOGICAL, 6., 2022. Rio de Janeiro. Annals... Rio de Janeiro: Bio-Manguinhos, 2022. p. 78.
dc.identifierhttps://www.arca.fiocruz.br/handle/icict/52151
dc.identifier10.35259/isi.2022_52151
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8850484
dc.descriptionOs autores externos submeteram sua publicação para apresentação de trabalho no evento “International Symposium on Immunobiologicals”, que foi coordenado e organizado pelo Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos), da Fundação Oswaldo Cruz.
dc.formatapplication/pdf
dc.languageeng
dc.publisherFiocruz/Instituto de Tecnologia em Imunobiológicos
dc.rightsopen access
dc.subjectDados do mundo real
dc.subjectAcesso a Medicamentos
dc.subjectMedicamentos Biossimilares
dc.subjectReal world data
dc.subjectMedicine Access
dc.subjectBiosimilars
dc.subjectMedicamentos Biossimilares
dc.titleDevelopment of a market projection methodology, based on clinical data, for decision making on investments in biosimilars
dc.typePapers presented at events


Este ítem pertenece a la siguiente institución